Found 46 matching trials
Efficacies of Antimicrobial Susceptibility-Guided Versus Empirical Therapy for Rescue Treatment of Helicobacter Pylori Infection
PHASE4The purpose of this study is to assess efficacy of 14-day antimicrobial sus...
The Role of Cathepsin X in Infection With the Helicobacter Pylori
N/AThe immune response to Helicobacter pylori (Hp) importantly determines the ...
Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori Eradication
PHASE3In this randomized controlled trial, we investigate the effect of 10-day bi...
Location
National Cancer Center
Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori
N/ATo survey the grade of gastric MALT lymphoma after eradication of Helicobac...
Location
Multiple Locations
Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori Treatment
PHASE4Helicobacter pylori (H. pylori), which infects about 50% of the global popu...
Location
Multiple Locations
One Sequencing Find All for Helicobacter Pylori Infection
N/AThe aim of this study is to Identify antibiotic resistance gene mutations i...
Location
Seoul National University Boramae Medical Center
Tailored H. Pylori Eradication Based on Clarithromycin Resistance
N/AThe investigators investigated the point mutations in the 23S rRNA genes of...
Location
Multiple Locations
The Efficacy of the 7 Days Tailored Therapy as 2nd Rescue Therapy for Eradication of H. Pylori Infection
NAAs increasing the antibiotics resistance, the effectiveness of traditional ...
Location
Seoul National University Bundang Hospital
Comparison of Keverprazan Hydrochloride-Amoxicillin Dual Therapy and Susceptibility-Guided Quadruple Therapy for Helicobacter Pylori Rescue Treatment
PHASE3This study aims to evaluate the efficacy and safety of Keverprazan Hydrochl...
Location
Multiple Locations
Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection.
PHASE3The aim of our study will be to assess in an open-label, multicenter, rando...